SCHEMBL24817127

SCHEMBL24817127

O=C(CS(=O)(=O)c1nccs1)N1Cc2ccc(Cl)cc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 1/20 0.40
▸ MAPT P10636 3/20 0.39
▸ USP2 O75604 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ GRM5 P41594 1/20 0.38
▸ NAMPT P43490 2/20 0.37
▸ CPT2 P23786 1/20 0.36
▸ CPT1A P50416 1/20 0.36
▸ LMNA P02545 1/20 0.34
▸ FAP Q12884 3/20 0.34
▸ HDAC8 Q9BY41 2/20 0.34
▸ DPP4 P27487 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ SLC6A9 P48067 1/20 0.33
▸ SLC6A5 Q9Y345 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29987551 0.90 MAOB (0.39) MAOBESR2GRM5NAMPTLMNA
SCHEMBL24815670 0.88 NLRP3 (0.35) MAPTUSP2ESR2HSD17B10GRM5
SCHEMBL24817122 0.86 NAMPT (0.44) NAMPTDPP4
SCHEMBL26845908 0.86 DPP8 (0.40) HSD17B10NAMPTLMNAFAPDPP4
SCHEMBL24815669 0.86 SMN1; SMN2 (0.42) NAMPTLMNAALDH1A1HPGDSMN1; SMN2
SCHEMBL29986905 0.86 SMN1; SMN2 (0.42) NAMPTLMNAALDH1A1HPGDSMN1; SMN2
SCHEMBL24814391 0.84 RYR2 (0.43) MAPTUSP2ESR2NAMPTLMNA
SCHEMBL24814740 0.83 NLRP3 (0.35) NAMPTSMN1; SMN2SCN3A
SCHEMBL24814401 0.83 DPP7 (0.43) MAPTNAMPTCPT2CPT1ALMNA
SCHEMBL24815798 0.82 NAMPT (0.42) NAMPTHDAC8ALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed
WO-2022251343-A2 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH MAOB 3502/4885MAPT 4407/4885USP2 244/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH MAOB 3502/4885MAPT 4407/4885USP2 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback